GRX Holdings Revenue and Competitors
Estimated Revenue & Valuation
- GRX Holdings's estimated annual revenue is currently $9.2M per year.
- GRX Holdings's estimated revenue per employee is $201,000
Employee Data
- GRX Holdings has 46 Employees.
- GRX Holdings grew their employee count by 10% last year.
GRX Holdings's People
Name | Title | Email/Phone |
---|---|---|
1 | VP Operations | Reveal Email/Phone |
2 | District Director Operations | Reveal Email/Phone |
3 | Director Clinical Pharmacy | Reveal Email/Phone |
4 | President | Reveal Email/Phone |
5 | System Administrator | Reveal Email/Phone |
6 | Human Resources Specialist | Reveal Email/Phone |
7 | CPhT., Operations Coordinator | Reveal Email/Phone |
8 | President | Reveal Email/Phone |
9 | Certified Pharmacy Technician | Reveal Email/Phone |
GRX Holdings Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $28.4M | 57 | 33% | $75.8M | N/A |
#2 | $1.2M | 6 | -73% | N/A | N/A |
#3 | $26.3M | 131 | 3% | N/A | N/A |
#4 | $33.4M | 166 | 2% | N/A | N/A |
#5 | $1073.9M | 5343 | 8% | N/A | N/A |
#6 | $9M | 45 | 10% | N/A | N/A |
#7 | $20.5M | 102 | 52% | N/A | N/A |
#8 | $20.1M | 100 | 37% | N/A | N/A |
#9 | $9.2M | 46 | 10% | N/A | N/A |
#10 | $3M | 15 | -56% | N/A | N/A |
What Is GRX Holdings?
Single overall owner of 20 Central Iowa Medicap Pharmacy locations, Medicap Pharmacy LTC, and Midwest Compounding. Our mission is to: - Provide consistent, quality personal service to our patients - Be genuinely concerned for our patient’s health - Provide our patients with needed health information - Always be readily available to our patients Check out more information at MyMedicapPharmacy.com.
keywords:N/AN/A
Total Funding
46
Number of Employees
$9.2M
Revenue (est)
10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $10.7M | 46 | -67% | N/A |
#2 | $10.8M | 50 | -4% | N/A |
#3 | $9.8M | 50 | 4% | N/A |
#4 | $7.5M | 54 | -7% | N/A |
#5 | $3.5M | 55 | -7% | N/A |